Crossmark

What is the impact of regulatory guidance and expiry of drug patents on dementia drug prescriptions in England? A trend analysis in the Clinical Practice Research Datalink

Crossref DOI link: https://doi.org/10.1186/s13195-018-0379-6

Published Online: 2018-05-29

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Walker, Venexia M.

Davies, Neil M.

Kehoe, Patrick G.

Martin, Richard M.
Funding

Funding for this research was provided by:

Perros Trust

MRC University of Bristol Integrative Epidemiology Unit (MC_UU_12013/9)

Sigmund Gestetner Foundation
License Information

Text and Data Mining valid from 2018-05-29
More Information

Article History

Received: 7 September 2017

Accepted: 1 May 2018

First Online: 29 May 2018

Ethics approval and consent to participate

: The protocol for this study was approved by the CPRD’s Independent Scientific Advisory Committee (ISAC protocol 15_246R). This study did not directly involve patients, so further ethical approval was not required.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below